emotive is an award-winning, global healthcare communications agency. We inspire change that has a positive impact on people’s health through our medical, scientific, brand, patient, PR and advocacy services. Our highly skilled, experienced team work with leading companies in life sciences including advanced therapy, medical device and rare disorder specialists in the pre, peri and post launch stages of the product lifecycle. We use our strategic scientific, creative and technical expertise to inspire engagement with HCPs, those living with a disorder and other stakeholders in the care pathway to stimulate advocacy and uptake of novel products. Working in rare disorders and with advanced therapies and orphan products, often comes with unique complexities and challenges. We have a wealth of experience supporting clients across a wide range of rare disorders with novel indications. Currently, 75% of our work is dedicated to rare and ultra-rare disorders at various stages of the product lifecycle and with advanced products such as gene therapies, gene silencing and cell therapies. As part of Synaptiq health, we work closely with our market access/HEOR consultancy partner, Initiate and our Market Research partner, Genactis. At a community level, we promote engagement in science by students through our sponsorship of the emotive. science lab and annual science prize at two UK state schools. We also work pro-bono on strategy, e-learning and awareness raising activities for M4RD (Medics for Rare Diseases), a charity committed to promoting greater awareness of rare diseases within the medical profession.